Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.39B 12.8B | Sales 2025 * | 9.45B 12.9B | Capitalization | 3.16B 4.31B |
---|---|---|---|---|---|
Net income 2024 * | 336M 458M | Net income 2025 * | 381M 520M | EV / Sales 2024 * | 2.46 x |
Net Debt 2024 * | 19.91B 27.15B | Net Debt 2025 * | 18.33B 25B | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
8.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+24.81% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.21% | 233B | |
+5.40% | 201B | |
-10.06% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |